BridgeBio to Participate in November Investor Conferences
BridgeBio (Nasdaq: BBIO) said members of its management team will present at two investor conferences in November 2025: a fireside chat at the UBS Global Healthcare Conference in Palm Beach Gardens, FL on Monday, November 10 at 1:15 pm ET, and a fireside chat at the Jefferies Global Healthcare Conference in London on Tuesday, November 18 at 11:00 am ET.
The company said live webcasts will be available on its Investors > Events and Presentations page and replay recordings will remain on the BridgeBio website for 90 days after each event.
BridgeBio (Nasdaq: BBIO) ha dichiarato che i membri del suo team dirigenziale parteciperanno a due conferenze per investitori a novembre 2025: un colloquio informale alla UBS Global Healthcare Conference a Palm Beach Gardens, FL, lunedì 10 novembre alle 13:15 ET, e un colloquio informale alla Jefferies Global Healthcare Conference a Londra, martedì 18 novembre alle 11:00 ET.
La società ha detto che le webcast in diretta saranno disponibili sulla pagina Investitori > Eventi e Presentazioni e che le registrazioni delle repliche resteranno sul sito di BridgeBio per 90 giorni dopo ciascun evento.
BridgeBio (Nasdaq: BBIO) dijo que los miembros de su equipo directivo presentarán en dos conferencias para inversionistas en noviembre de 2025: una charla junto a la chimenea en la UBS Global Healthcare Conference en Palm Beach Gardens, FL, el lunes 10 de noviembre a las 13:15 ET, y una charla junto a la chimenea en la Jefferies Global Healthcare Conference en Londres, el martes 18 de noviembre a las 11:00 ET.
La empresa dijo que las transmisiones en vivo estarán disponibles en su página de Inversionistas > Eventos y Presentaciones y que las grabaciones de las retransmisiones permanecerán en el sitio web de BridgeBio durante 90 días después de cada evento.
BridgeBio (Nasdaq: BBIO)는 2025년 11월 두 차례의 투자자 컨퍼런스에서 경영진이 발표할 예정이라고 밝혔다: UBS Global Healthcare Conference가 Palm Beach Gardens, FL에서 열리는 불로 대담 형식의 발표를 11월 10일 월요일 동부표시시 13:15에 진행하고, Jefferies Global Healthcare Conference가 런던에서 열리는 불로 대담 형식의 발표를 11월 18일 화요일 11:00에 진행한다.
회사 측은 라이브 웹캐스트가 Investors > Events and Presentations 페이지에서 이용 가능하고, 각 이벤트 후 재생 recording은 90일간 BridgeBio 웹사이트에 남아 있을 것이라고 말했다.
BridgeBio (Nasdaq: BBIO) a déclaré que des membres de son équipe de direction présenteraient lors de deux conférences destinées aux investisseurs en novembre 2025 : un entretien informel lors de la UBS Global Healthcare Conference à Palm Beach Gardens, FL, le lundi 10 novembre à 13h15 HE, et un entretien informel lors de la Jefferies Global Healthcare Conference à Londres, le mardi 18 novembre à 11h00 HE.
La société a indiqué que les webdiffusions en direct seront disponibles sur sa page Investisseurs > Événements et Présentations et que les enregistrements des rediffusions resteront sur le site BridgeBio pendant 90 jours après chaque événement.
BridgeBio (Nasdaq: BBIO) gab bekannt, dass Mitglieder des Management-Teams an zwei Investorenkonferenzen im November 2025 teilnehmen werden: ein Fireside-Chat bei der UBS Global Healthcare Conference in Palm Beach Gardens, FL, am Montag, dem 10. November um 13:15 Uhr ET, und ein Fireside-Chat bei der Jefferies Global Healthcare Conference in London am Dienstag, dem 18. November um 11:00 Uhr ET.
Das Unternehmen erklärte, dass Live-Webcasts auf seiner Seite Investoren > Veranstaltungen und Präsentationen verfügbar sein werden und dass Replay-Aufzeichnungen 90 Tage lang nach jeder Veranstaltung auf der BridgeBio-Website verbleiben.
BridgeBio (Nasdaq: BBIO) قال أعضاء من فريق الإدارة إنهم سيقدمون في مراسم استثمارية في نوفمبر 2025: دردشة بجلسة نار باردية في UBS Global Healthcare Conference في Palm Beach Gardens, FL يوم الاثنين 10 نوفمبر في الساعة 13:15 بتوقيت شرق الولايات المتحدة، ودردشة بجلسة نار باردة في Jefferies Global Healthcare Conference في لندن يوم الثلاثاء 18 نوفمبر الساعة 11:00 صباحاً بتوقيت شرق الولايات المتحدة.
قالت الشركة إن البثوث الحية ستكون متاحة على صفحة المستثمرين > الفعاليات والعروض، وإن تسجيلات الإعادة ستبقى على موقع BridgeBio لمدة 90 يوماً بعد كل حدث.
- None.
- None.
PALO ALTO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will host fireside chats at the following healthcare investor conferences:
- UBS Global Healthcare Conference, Palm Beach Gardens, FL: Fireside Chat on Monday, November 10 at 1:15 pm EST
- Jefferies Global Healthcare Conference, London, UK: Fireside Chat on Tuesday, November 18 at 11:00 am EST
To access the live webcast of BridgeBio’s presentations, please visit the “Events and Presentations” page within the Investors section of the BridgeBio website at https://investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.
About BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (BridgeBio; Nasdaq: BBIO) is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn, X, Facebook, Instagram, and YouTube.
BridgeBio Media Contact:
Bubba Murarka, Executive Vice President, Corporate Development
contact@bridgebio.com
(650)-789-8220
BridgeBio Investor Contact:
Chinmay Shukla, Senior Vice President, Strategic Finance
ir@bridgebio.com
FAQ
When will BridgeBio (BBIO) present at the UBS Global Healthcare Conference in November 2025?
What time is BridgeBio's (BBIO) Jefferies Global Healthcare Conference fireside chat in November 2025?
How can investors watch BridgeBio (BBIO) live webcasts for the November 2025 conferences?
Will BridgeBio (BBIO) provide replays of the November 2025 conference presentations?
Which BridgeBio (BBIO) executives will appear at the November 2025 conference fireside chats?
